Tokyo, Japan

Junji Nishigaki

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignees: Savid Therapeutics Inc., The University of Tokyo. Active years: 2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Junji Nishigaki. Retrieved from https://idiyas.com/inventor/junji-nishigaki-g2fz52c5

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 10.0

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Junji Nishigaki: Innovator in Photoimmunotherapy

Introduction

Junji Nishigaki is a notable inventor based in Tokyo, Japan. He has made significant contributions to the field of photoimmunotherapy through his innovative research and development.

Latest Patents

Nishigaki holds a patent for a conjugate of a biotin-modified dimer and a phthalocyanine dye. This invention aims to provide a conjugate that is utilized in photoimmunotherapy. The compound is represented by a specific formula, which includes a salt thereof.

Career Highlights

Throughout his career, Junji Nishigaki has worked with prestigious institutions, including The University of Tokyo and Savid Therapeutics Inc. His work has focused on advancing medical technologies and therapeutic methods.

Collaborations

Nishigaki has collaborated with notable colleagues such as Motomu Kanai and Kenzo Yamatsugu. Their joint efforts have contributed to the advancement of research in their respective fields.

Conclusion

Junji Nishigaki's innovative work in photoimmunotherapy highlights his role as a key inventor in the medical technology sector. His contributions continue to influence advancements in therapeutic applications.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…